Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
Vaxart (NASDAQ: VXRT) has announced it will provide a business update and report financial results for the second quarter ended June 30, 2024, after the market close on Thursday, August 8, 2024. The company's senior management team will host a conference call on the same day at 4:30 p.m. ET. Investors can access the call via webcast or by phone using specific dial-in numbers. Written questions can be submitted in advance to ir@vaxart.com. A replay of the webcast will be available on Vaxart's website following the event.
Vaxart (NASDAQ: VXRT) ha annunciato che fornirà un aggiornamento aziendale e riporterà i risultati finanziari per il secondo trimestre terminato il 30 giugno 2024, dopo la chiusura del mercato il giovedì 8 agosto 2024. Il team di gestione senior dell'azienda ospiterà una teleconferenza lo stesso giorno alle 16:30 ET. Gli investitori possono accedere alla chiamata tramite webcast o per telefono utilizzando numeri specifici di accesso. Le domande scritte possono essere inviate in anticipo a ir@vaxart.com. Una registrazione del webcast sarà disponibile sul sito web di Vaxart dopo l'evento.
Vaxart (NASDAQ: VXRT) ha anunciado que proporcionará una actualización comercial e informará sobre los resultados financieros del segundo trimestre finalizado el 30 de junio de 2024, después del cierre del mercado el jueves 8 de agosto de 2024. El equipo de alta dirección de la empresa organizará una conferencia telefónica el mismo día a las 4:30 p.m. ET. Los inversores pueden acceder a la llamada a través de un webcast o por teléfono utilizando números de marcado específicos. Las preguntas escritas se pueden enviar con anticipación a ir@vaxart.com. Una repetición del webcast estará disponible en el sitio web de Vaxart después del evento.
Vaxart (NASDAQ: VXRT)는 2024년 6월 30일로 종료된 2분기 재무 결과를 발표하고 비즈니스 업데이트를 제공할 것임을 발표했습니다. 이 발표는 2024년 8월 8일 목요일 주식시장 마감 후 이루어질 예정입니다. 회사의 고위 경영진 팀은 같은 날 오후 4시 30분 ET에 전화 회의를 주최할 것입니다. 투자자들은 특정 전화 접속 번호를 사용하여 웹캐스트 또는 전화를 통해 회의에 접속할 수 있습니다. 서면 질문은 ir@vaxart.com으로 미리 제출할 수 있습니다. 웹캐스트의 녹화는 행사 후 Vaxart 웹사이트에서 제공될 예정입니다.
Vaxart (NASDAQ: VXRT) a annoncé qu'il fournira une mise à jour de ses activités et présentera les résultats financiers du deuxième trimestre clos le 30 juin 2024, après la fermeture du marché le jeudi 8 août 2024. L'équipe de direction senior de l'entreprise animera une téléconférence le même jour à 16h30 ET. Les investisseurs peuvent accéder à l'appel via un webinaire ou par téléphone en utilisant des numéros de composition spécifiques. Des questions écrites peuvent être soumises à l'avance à ir@vaxart.com. Un enregistrement de la diffusion Web sera disponible sur le site Web de Vaxart après l'événement.
Vaxart (NASDAQ: VXRT) hat bekannt gegeben, dass es ein Unternehmensupdate bereitstellen und die Finanzergebnisse für das zweite Quartal zum 30. Juni 2024 nach Börsenschluss am Donnerstag, den 8. August 2024 bekannt geben wird. Das Senior Management-Team des Unternehmens wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz durchführen. Investoren können über einen Webcast oder per Telefon mit spezifischen Einwahlnummern auf die Konferenz zugreifen. Schriftliche Fragen können im Voraus an ir@vaxart.com gesendet werden. Ein Replay des Webcasts wird nach der Veranstaltung auf der Website von Vaxart verfügbar sein.
- None.
- None.
Conference call to begin at 4:30 p.m. ET
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2024 after the market close on Thursday, August 8, 2024. The Vaxart senior management team will host a conference call on the same day, beginning at 4:30 p.m. ET.
The conference call can be accessed using the following information:
Webcast: Click here
Date: Thursday, August 8, 2024 – 4:30 p.m. ET
Domestic: (866) 682-6100
International: (862) 298-0702
Conference ID: 13747081
Investors may submit written questions in advance of the conference call to ir@vaxart.com.
A replay of the webcast will be available on the Company’s website at www.vaxart.com following the conclusion of the event.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
| Contacts | ||
| Vaxart Media Relations: | Investor Relations: | |
| Mark Herr | Andrew Blazier | |
| Vaxart, Inc. | FINN Partners | |
| mherr@vaxart.com | IR@vaxart.com | |
| (203) 517-8957 | ||
FAQ
When will Vaxart (VXRT) release its Q2 2024 financial results?
What time is Vaxart's (VXRT) Q2 2024 earnings call scheduled for?
How can investors access Vaxart's (VXRT) Q2 2024 earnings call?
Can investors submit questions for Vaxart's (VXRT) Q2 2024 earnings call?
